Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital toolkit aims to empower families in the opioid crisis

NCT ID NCT07795840

Symptom relief Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This trial tests a digital program called ConCERN for friends and family members of people with opioid use disorder. The program provides educational modules to reduce stigma, improve communication, and help navigate treatment options. Researchers will measure changes in the support person's confidence and knowledge, as well as the opioid user's behavior. The goal is to see if this brief online intervention can improve well-being for both the support person and their loved one.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ConCERN intervention, a digital educational program for concerned significant others of people with opioid use disorder
What this could lead to
If it works, this could provide a simple, scalable way to help friends and family support loved ones with opioid use disorder, potentially improving outcomes for both.
What could go wrong
The trial is early and relies on self-reported measures, so the program may not produce lasting changes. Also, the digital format may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 700 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

CSOs (Randomized participants) Inclusion Criteria: * Identifies as a support person of a PWUO * Communicated with PWUO in the past 6 months PWUO (Randomized participants) Inclusion Criteria: * Identifies as a PWUO * Has used opioids in the past 6 months * Can name a CSO and provide their contact information CSOs (Randomized participants) Exclusion Criteria: * Can't read English * Doesn't have email and phone/tablet/computer access * Located outside of the U.S. PWUO (Randomized participants) Exclusion Criteria: * Can't read English * Doesn't have email access * Located outside of the U.S. * CSOs they named they named doesn't enroll in study * Does not complete baseline survey within 30 days of CSO baseline survey completion date

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid-use disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioid-use disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    2 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

    Contact Email: •••••@•••••

  • Wayne State University

    Detroit, Michigan, 48202, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.